Cleared Traditional

K161521 - TAP Blood Collection Device (FDA 510(k) Clearance)

Feb 2017
Decision
259d
Days
Class 2
Risk

K161521 is an FDA 510(k) clearance for the TAP Blood Collection Device. This device is classified as a Capillary Blood Collection Device For Alternative Site Collection (Class II - Special Controls, product code PRJ).

Submitted by Seventh Sense Biosystems, Inc. (Medford, US). The FDA issued a Cleared decision on February 16, 2017, 259 days after receiving the submission on June 2, 2016.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1675. A Capillary Blood Collection Device With Or Without Integrated Micro-needles Is A Blood Collection Device Intended To Collect And/or Transport Capillary Whole Blood Specimens For Testing Of Clinical Analytes..

Submission Details

510(k) Number K161521 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 02, 2016
Decision Date February 16, 2017
Days to Decision 259 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code PRJ - Capillary Blood Collection Device For Alternative Site Collection
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1675
Definition A Capillary Blood Collection Device With Or Without Integrated Micro-needles Is A Blood Collection Device Intended To Collect And/or Transport Capillary Whole Blood Specimens For Testing Of Clinical Analytes.